scholarly journals Role of the staphylococcal nuclease and tudor domain containing 1 in oncogenesis (Review)

2014 ◽  
Vol 46 (2) ◽  
pp. 465-473 ◽  
Author(s):  
NIDHI JARIWALA ◽  
DEVARAJA RAJASEKARAN ◽  
JYOTI SRIVASTAVA ◽  
RACHEL GREDLER ◽  
MAAGED A. AKIEL ◽  
...  
Epigenomes ◽  
2021 ◽  
Vol 5 (1) ◽  
pp. 2
Author(s):  
Tanner Wright ◽  
Yalong Wang ◽  
Mark T. Bedford

Arginine methylation is an essential post-translational modification (PTM) deposited by protein arginine methyltransferases (PRMTs) and recognized by Tudor domain-containing proteins. Of the nine mammalian PRMTs, PRMT5 is the primary enzyme responsible for the deposition of symmetric arginine methylation marks in cells. The staphylococcal nuclease and Tudor domain-containing 1 (SND1) effector protein is a key reader of the marks deposited by PRMT5. Both PRMT5 and SND1 are broadly expressed and their deregulation is reported to be associated with a range of disease phenotypes, including cancer. Hepatocellular carcinoma (HCC) is an example of a cancer type that often displays elevated PRMT5 and SND1 levels, and there is evidence that hyperactivation of this axis is oncogenic. Importantly, this pathway can be tempered with small-molecule inhibitors that target PRMT5, offering a therapeutic node for cancer, such as HCC, that display high PRMT5–SND1 axis activity. Here we summarize the known activities of this writer–reader pair, with a focus on their biological roles in HCC. This will help establish a foundation for treating HCC with PRMT5 inhibitors and also identify potential biomarkers that could predict sensitivity to this type of therapy.


FEBS Journal ◽  
2005 ◽  
Vol 272 (15) ◽  
pp. 3960-3966 ◽  
Author(s):  
Zhengding Su ◽  
Jiun-Ming Wu ◽  
Huey-Jen Fang ◽  
Tian-Yow Tsong ◽  
Hueih-Min Chen

2008 ◽  
Vol 48 (supplement) ◽  
pp. S22
Author(s):  
Shigehumi Tadokoro ◽  
Hironari Kamikubo ◽  
Shigeo Yamaguchi ◽  
Yoichi Yamazaki ◽  
Mikio Kataoka

2002 ◽  
Vol 42 (supplement2) ◽  
pp. S193
Author(s):  
S. Hirano ◽  
H. Kamikubo ◽  
Y. Yamazaki ◽  
Y. Imamoto ◽  
M. Kataoka

2013 ◽  
Vol 53 (supplement1-2) ◽  
pp. S215
Author(s):  
Rumi Shiba ◽  
Hironari Kamikubo ◽  
Yutaka Maruyama ◽  
Junko Yunoki ◽  
Keiichi Fukuyama ◽  
...  

1977 ◽  
Vol 145 (1) ◽  
pp. 123-135 ◽  
Author(s):  
J A Berzofsky ◽  
A N Schechter ◽  
G M Shearer ◽  
D H Sachs

The relative proportions of antibodies of different specificities within antisera raised to native staphylococcal nuclease have been studied in several strains of mice in which the antibody response has been shown to be under H-2-linked Ir-gene control. A method was developed in which binding to different radiolabeled fragments of nuclease was titrated against increasing fragment concentration until the binding capacity of the antiserum for that fragment was saturated. In comparing the low responder (H-2b) strain C57BL/10 with its congenic high responder counterpart B10.A (H-2a), it was found that the two strains made markedly and reproducibly different proportions of antibodies to different determinants on native nuclease. Since these two strains differ only at H-2, and therefore have identical immunoglobulin structural gene repertoires, we conclude that H-2-linked Ir genes can control the response to different determinants on the same antigen molecule independently of one another. This result suggests a possible role of H-2-linked genes in the selection of specific B cells.


2008 ◽  
Vol 48 (supplement) ◽  
pp. S35
Author(s):  
Reine Nakagaki ◽  
Hironari Kamikubo ◽  
Yoichi Yamazaki ◽  
Mikio Kataoka

FEBS Journal ◽  
2005 ◽  
Vol 272 (15) ◽  
pp. 3967-3974 ◽  
Author(s):  
Hueih-Min Chen ◽  
Siu-Chiu Chan ◽  
King-Wong Leung ◽  
Jiun-Ming Wu ◽  
Huey-Jen Fang ◽  
...  

2016 ◽  
Vol 291 (20) ◽  
pp. 10736-10746 ◽  
Author(s):  
Devaraja Rajasekaran ◽  
Nidhi Jariwala ◽  
Rachel G. Mendoza ◽  
Chadia L. Robertson ◽  
Maaged A. Akiel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document